BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
3.380
+0.123 (3.78%)
At close: Dec 5, 2025, 4:00 PM EST
3.360
-0.020 (-0.59%)
After-hours: Dec 5, 2025, 4:10 PM EST
BioLineRx Market Cap
BioLineRx has a market cap or net worth of $13.69 million as of December 5, 2025. Its market cap has decreased by -64.35% in one year.
Market Cap
13.69M
Enterprise Value
-438.62K
1-Year Change
-64.35%
Ranking
Category
Stock Price
$3.38
Market Cap Chart
Since July 27, 2009, BioLineRx's market cap has decreased from $33.80M to $13.69M, a decrease of -59.49%. That is a compound annual growth rate of -5.37%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |